Critical treatment choices for patients with platinum-refractory urothelial carcinoma

Research output: Contribution to journal › Comment/debate › peer-review

ASJC Scopus subject areas

@article{b33a7aab384a45ecb4e3c73cf81be489,

title = "Critical treatment choices for patients with platinum-refractory urothelial carcinoma",

author = "Yair Lotan and Xiaosong Meng",

year = "2020",

month = jan,

doi = "10.1016/S1470-2045(19)30661-8",

language = "English (US)",

volume = "21",

pages = "11--13",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "1",

}

TY - JOUR

T1 - Critical treatment choices for patients with platinum-refractory urothelial carcinoma

AU - Lotan, Yair

AU - Meng, Xiaosong

PY - 2020/1

Y1 - 2020/1

UR - http://www.scopus.com/inward/record.url?scp=85077164568&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85077164568&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(19)30661-8

DO - 10.1016/S1470-2045(19)30661-8

M3 - Comment/debate

C2 - 31753728

AN - SCOPUS:85077164568

SN - 1470-2045

VL - 21

SP - 11

EP - 13

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 1

ER -